In this study, we found that the downregulated PRKAR2B expression in glomerular tissue may indicate the deterioration of kidney function in patients with DN, and so did the upregulated TGFBI in tubulointerstitial tissue. Here, PRKAR2B is linked to liver dysplastic nodule.